No Picture
Los Angeles Biotech News

NKMax America Presents Promising Clinical Research Findings at 2020 ASCO Virtual Conference

SANTA ANA, Calif., May 29, 2020 (GLOBE NEWSWIRE) — NKMax America, a biotechnology company harnessing the power of the body’s immune system through the development of Natural Killer (NK) cell therapies, announced the publication of three abstracts in… […]

No Picture
Los Angeles Biotech News

Sierra Oncology brings on former Aimmune CEO to the helm; Flagship woos ex-Novartis exec Fabrice Chouraqui

Stephen Dilly
→ Momelotinib-focused Sierra Oncology, which launched a Phase III trial in November for myelofibrosis patients, has made Stephen Dilly its president and CEO, effective June 1. Dilly was previously the CEO at Aimmune from 2014 until what w… […]

No Picture
Los Angeles Biotech News

Annenberg Foundation and Two Bit Circus Foundation Ignite Lifelong Love for Arts and Sciences with Free STEAM-Based Online Projects

LOS ANGELES–(BUSINESS WIRE)– #AnnenbergLearner–Two Bit Circus Foundation, a nonprofit educational organization, announced today it is collaborating with the Annenberg Foundation’s educational division, Annenberg Learner, to provide free access to ov… […]

No Picture
Los Angeles Biotech News

ChromaDex to Participate in Panel on Master Files for Dietary Supplements Hosted by the American Conference Institute (ACI) and Council for Responsible Nutrition (CRN)

LOS ANGELES–(BUSINESS WIRE)—- $CDXC #CellularHealth–ChromaDex Corp. (NASDAQ:CDXC) today announced its participation in a panel discussion titled “What New Dietary Ingredient Master Files Mean for Innovation & Compliance,” hosted by the American… […]

No Picture
Los Angeles Biotech News

Opiant Pharmaceuticals to Present at the 2020 Jefferies Virtual Healthcare Conference

SANTA MONICA, Calif., May 26, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today that its Chief Executive Officer,… […]

No Picture
Los Angeles Biotech News

Capricor to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27, 2020

LOS ANGELES, May 26, 2020 (GLOBE NEWSWIRE) — Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment and prevention of diseases,… […]